amodiaquine has been researched along with Alloxan Diabetes in 2 studies
Amodiaquine: A 4-aminoquinoline compound with anti-inflammatory properties.
amodiaquine : A quinoline having a chloro group at the 7-position and an aryl amino group at the 4-position.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Kang, JM | 2 |
Lee, HS | 1 |
Kim, J | 2 |
Yang, DH | 2 |
Jeong, HY | 2 |
Lee, YH | 1 |
Kim, DJ | 2 |
Park, SH | 2 |
Sung, M | 1 |
An, HJ | 1 |
Lee, SH | 2 |
Lee, SY | 2 |
Jun, HH | 1 |
Sung, MJ | 1 |
Heo, JH | 1 |
2 other studies available for amodiaquine and Alloxan Diabetes
Article | Year |
---|---|
Beneficial Effect of Chloroquine and Amodiaquine on Type 1 Diabetic Tubulopathy by Attenuating Mitochondrial Nox4 and Endoplasmic Reticulum Stress.
Topics: Amodiaquine; Animals; Apoptosis; Cells, Cultured; Chloroquine; Diabetes Mellitus, Experimental; Diab | 2020 |
Chloroquine and amodiaquine enhance AMPK phosphorylation and improve mitochondrial fragmentation in diabetic tubulopathy.
Topics: Amodiaquine; AMP-Activated Protein Kinases; Animals; Antimalarials; Cell Line; Chloroquine; Diabetes | 2018 |